Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp (ADPT) Option Chain
Read more
Tracking the ADPT option chain helps you see every strike and expiry on Adaptive Biotechnologies Corp in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ADPT options activity at a glance. Use our scanner to monitor the ADPT option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ADPT stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ADPT options are being actively traded, and where they are not.
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 8.36 | 0 | 0 | -0.58 | 7.98 | 5.30 | 9.50 | 20.00 | -25.46 | — | 5.00 | 0.00 | 5.00 | 0 | 0 | 91.64 |
| 21.45 | 1 | 0 | -0.33 | 5.48 | 3.30 | 7.00 | 22.50 | -16.14 | — | 1.50 | 0.00 | 1.50 | 0 | 1,427 | 78.55 |
| 39.64 | 26 | 0 | 0.27 | 2.98 | 1.50 | 5.00 | 25.00 | -6.82 | — | 2.25 | 0.00 | 2.25 | 0 | 16 | 60.36 |
| 74.26 | 1,590 | 64 | 2.25 | 0.00 | 0.50 | 4.00 | 30.00 | +11.82 | 3.00 | 6.50 | 2.02 | 2.73 | 0 | 9 | 25.74 |
| 92.28 | 107 | 0 | 2.50 | 0.00 | — | 2.50 | 35.00 | +30.45 | 7.50 | 11.00 | 7.02 | 2.23 | 0 | 1 | 7.72 |
As of Nov 5, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryDiagnostics & Research
- SectorHealthcare
- IV Rank48.41% Moderate
- Market cap (M$)4,282
- 52 weeks high-12.72%
- 52 weeks low123.58%
- Analyst recommendationStrong Buy
1.00 - Target price$30.50
7.97% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2027-02-04
- P/E—
- Future P/E—
- EPS (ttm)-0.45
- EPS growth next 5 years—
As of Nov 5, 2026